Enclear Therapies, Inc.
Publicly observedNewburyport, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Newburyport | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Enclear Therapies, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | CZ53WXM52XT5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Jul 2024Publicly observed
NIH SBIR/STTR award: Smart CSF Delivery System for CNS Drug Therapy for Leptomeningeal Disease
USD 150,000.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jul 2024Publicly observed
NIH SBIR/STTR award: Smart CSF Delivery System for CNS Drug Therapy for Leptomeningeal Disease
USD 107,649.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jan 2024Publicly observed
NIH SBIR/STTR award: Targeted Cerebral Spinal Fluid (CSF) Drug Delivery - Enclear Precision System
USD 2,977,025.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.